A multiple-center, randomized, double-blind, placebo-controlled, parallel-group comparison study in idiopathic carpal tunnel syndrome

Trial Profile

A multiple-center, randomized, double-blind, placebo-controlled, parallel-group comparison study in idiopathic carpal tunnel syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 25 May 2016

At a glance

  • Drugs Limaprost (Primary)
  • Indications Carpal tunnel syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Ono Pharmaceutical; Sumitomo Dainippon Pharma
  • Most Recent Events

    • 25 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top